Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anke Hengyi Pharmaceutical is a prominent Chinese pharmaceutical company and a key subsidiary of Anhui Anke Biotechnology (Group) Co., Ltd. Based in Lu'an, Anhui Province, the company focuses on the research, production, and sale of chemical drugs across various therapeutic categories, including anti-infectives, cardiovascular, and respiratory medicine. It operates modern, GMP-certified manufacturing facilities capable of producing multiple dosage forms such as tablets, capsules, and granules. The company is well-regarded for its high-quality generic medications and its active participation in the consistency evaluation of chemical drugs in China. Anke Hengyi serves as the primary chemical drug manufacturing arm of its parent group, integrating traditional pharmaceutical production with modern R&D to support domestic healthcare needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 安徽安科恒益药业.